Heparin/heparosan synthase from
View Patent ↗The presently claimed and disclosed invention relates, in general, to dual action heparin synthases and, more particularly, to dual action heparin synthases obtained from Pasteurella multocida . The presently claimed and disclosed invention also relates to heparosan, heparin and heparin-like molecules provided by recombinant techniques and methods of using such molecules and also the identification or prediction of heparin synthases or component single action enzymes. The presently claimed and disclosed invention also relates to methods, and molecules produced according to such methods, for using the presently claimed and disclosed heparosan and/or heparin synthase for polymer grafting and the production of non-naturally occurring chimeric polymers incorporating stretches of one or more acidic GAG molecules, such as heparin, chondroitin, hyaluronan, and/or heparosan.
1. A purified nucleic acid segment having a coding region encoding heparin synthase, wherein the heparin synthase is a single protein that is a dual-action catalyst that utilizes UDP-GlcUA and UDP-GlcNAc to synthesize heparin, wherein the purified nucleic acid segment is a truncated segment when compared to the nucleotide sequence of SEQ ID NO:1 or 3.
2. A purified nucleic acid segment comprising a coding region encoding heparin synthase, wherein the heparin synthase is a single protein that is a dual-action catalyst that utilizes UDP-GlcUA and UDP-GlcNAc to synthesize heparin, and wherein the purified nucleic acid segment encodes the Pasteurella multocida heparin synthase of SEQ ID NO:2 or 4.
3. A purified nucleic acid segment comprising a coding region encoding heparin synthase, wherein the heparin synthase is a single protein that is a dual-action catalyst that utilizes UDP-GlcUA and UDP-GlcNAc to synthesize heparin, and wherein the purified nucleic acid segment comprises a nucleotide sequence in accordance with SEQ ID NO:1 or 3.
4. A recombinant vector selected from the group consisting of a plasmid, cosmid, phage, integrated cassette or virus vector and wherein the recombinant vector further comprises a purified nucleic acid segment having a coding region encoding heparin synthase, wherein the heparin synthase is a single protein that is a dual-action catalyst that utilizes UDP-GlcUA and UDP-GlcNAc to synthesize heparin, and wherein the purified nucleic acid segment encodes the Pasteurella multocida heparin synthase of SEQ ID NO:2 or 4.
5. The recombinant vector of claim 4 , wherein the plasmid further comprises an expression vector.
6. The recombinant vector of claim 4 , wherein the expression vector comprises a promoter operatively linked to the heparin synthase coding region.
7. A recombinant vector selected from the group consisting of a plasmid, cosmid, phage, integrated cassette or virus vector and wherein the recombinant vector further comprises a purified nucleic acid segment having a coding region encoding heparin synthase, wherein the heparin synthase is a single protein that is a dual-action catalyst that utilizes UDP-GlcUA and UDP-GlcNAc to synthesize heparin, and wherein the purified nucleic acid segment comprises a nucleotide sequence in accordance with SEQ ID NO:1 or 3.
8. The recombinant vector of claim 7 , wherein the plasmid further comprises an expression vector.
9. The recombinant vector of claim 7 , wherein the expression vector comprises a promoter operatively linked to the heparin synthase coding region.
10. A recombinant host cell, wherein the recombinant host cell is electroporated, transformed, transfected or transduced to introduce a recombinant vector into the recombinant host cell, wherein the recombinant vector comprises a purified nucleic acid segment having a coding region encoding heparin synthase, wherein the heparin synthase is a single protein that is a dual-action catalyst that utilizes UDP-GlcUA and UDP-GlcNAc to synthesize heparin, and wherein the purified nucleic acid segment encodes the Pasteurella multocida heparin synthase of SEQ ID NO:2 or 4.
11. The recombinant host cell of claim 10 , wherein the host cell produces heparin.
12. The recombinant host cell of claim 10 , wherein the recombinant host cell is a prokaryotic cell.
13. The recombinant host cell of claim 10 , wherein the recombinant host cell is a eukaryotic cell.
14. A recombinant host cell, wherein the recombinant host cell is electroporated, transformed, transfected or transduced to introduce a recombinant vector into the recombinant host cell, wherein the recombinant vector comprises a purified nucleic acid segment having a coding region encoding heparin synthase, wherein the heparin synthase is a single protein that is a dual-action catalyst that utilizes UDP-GlcUA and UDP-GlcNAc to synthesize heparin, and wherein the purified nucleic acid segment comprises a nucleotide sequence in accordance with SEQ ID NO:1 or 3.
15. The recombinant host cell of claim 14 , wherein the host cell produces heparin.
16. The recombinant host cell of claim 14 , wherein the recombinant host cell is a prokaryotic cell.
17. The recombinant host cell of claim 14 , wherein the recombinant host cell is a eukaryotic cell.